Literature DB >> 18468934

HOMA or QUICKI: is it useful to test the reproducibility of formulas?

B Antuna-Puente1, M Faraj, A D Karelis, D Garrel, D Prud'homme, R Rabasa-Lhoret, J-P Bastard.   

Abstract

AIM: HOMA and QUICKI are the most widely used indices for assessing insulin sensitivity. Both are based on fasting glucose and insulin measures, and mainly differ by the log transformation of these variables in QUICKI. However, HOMA is less reproducible than QUICKI, and log HOMA does not improve its reproducibility. The aim of this study was to investigate the various mathematical transformations of HOMA and to assess its reproducibility.
METHOD: We used data from a clamp study involving 123 non-diabetic overweight and obese postmenopausal women. Fasting insulin and glucose were measured in two visits 15 and 30 days apart. This allowed us to calculate HOMA as (fasting glucose [mmol/L] x fasting insulin [microU/mL])/22.5 and QUICKI as 1/(log fasting glucose [mg/dL]+log fasting insulin [microU/mL]) twice for subjects who were weight-stable between visits.
RESULTS: QUICKI had better reproducibility (CV=3.9%) than either HOMA (CV=26.7%) or log HOMA (CV=22.0%). However, log-transforming HOMA using log (glucose x insulin)/log (22.5) and log-transforming HOMA without transforming the constant denominator improved its CV to 6.5% and 5.7%, respectively.
CONCLUSION: By modifying the mathematical expression of HOMA, we were able to achieve comparable CVs for QUICKI and HOMA. However, the CV should be used to assess the reproducibility of techniques to measure glucose and insulin, not of mathematical formulas. When evaluating indices for the assessment of insulin sensitivity, the key point is how well they correlate with the 'gold-standard' glucose clamp.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468934     DOI: 10.1016/j.diabet.2008.02.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  10 in total

1.  Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women.

Authors:  Montserrat Broch; José Manuel Gómez; Ma Teresa Auguet; Nuria Vilarrasa; Rosa Pastor; Iñaki Elio; Montserrat Olona; Antonio García-España; Cristóbal Richart
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

Review 2.  Neurogenic Obesity-Induced Insulin Resistance and Type 2 Diabetes Mellitus in Chronic Spinal Cord Injury.

Authors:  Phillip S Gordon; Gary J Farkas; David R Gater
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

3.  Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.

Authors:  Karen Frankwich; Courtney Tibble; Moises Torres-Gonzalez; Mariah Bonner; Roy Lefkowitz; Matt Tyndall; Geert W Schmid-Schönbein; Francisco Villarreal; Mike Heller; Karen Herbst
Journal:  J Inflamm (Lond)       Date:  2012-10-01       Impact factor: 4.981

Review 4.  Insulin resistance and skin diseases.

Authors:  Maddalena Napolitano; Matteo Megna; Giuseppe Monfrecola
Journal:  ScientificWorldJournal       Date:  2015-04-21

5.  SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation.

Authors:  Annie Bouchard-Mercier; Iwona Rudkowska; Simone Lemieux; Patrick Couture; Louis Pérusse; Marie-Claude Vohl
Journal:  Lipids Health Dis       Date:  2014-10-01       Impact factor: 3.876

6.  Comparison of Various Indices in Identifying Insulin Resistance and Diabetes in Chronic Spinal Cord Injury.

Authors:  Gary J Farkas; Phillip S Gordon; Nareka Trewick; Ashraf S Gorgey; David R Dolbow; Eduard Tiozzo; Arthur S Berg; David R Gater
Journal:  J Clin Med       Date:  2021-11-28       Impact factor: 4.241

7.  Interleukin-8, CXCL10, CXCL11 and their role in insulin resistance in adult females with subclinical hypothyroidism and prediabetes.

Authors:  Roxana Adriana Stoica; Nicoleta Drăgana; Robert Ancuceanu; Ovidiu Ionuț Geicu; Cristian Guja; Anca Pantea-Stoian; Damaris-Cristina Gheorghe; Raluca-Ioana Stefan-van Staden; Cristian Serafinceanu; Adrian Costache; Constantin Ionescu-Tîrgoviște
Journal:  J Clin Transl Endocrinol       Date:  2022-04-06

8.  Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Hongying Sun; Shuqing Chen
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

9.  Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.

Authors:  M P van der Aa; M A J Elst; E M W van de Garde; E G A H van Mil; C A J Knibbe; M M J van der Vorst
Journal:  Nutr Diabetes       Date:  2016-08-29       Impact factor: 5.097

10.  Ectopic pancreatic fat as a risk factor for hypertension in children and adolescents with nonalcoholic fatty liver disease.

Authors:  Eun Hye Lee; Ji Young Kim; Hye Ran Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-07-16       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.